Homoharringtonine is a safe and effective substitute for anthracyclines in children younger than 2 years old with acute myeloid leukemia

{{article.zuoZheEn}}

PDF(679 KB)
PDF(679 KB)
Front. Med. ›› 2019, Vol. 13 ›› Issue (3) : 378-387. DOI: 10.1007/s11684-018-0658-4
RESEARCH ARTICLE

Homoharringtonine is a safe and effective substitute for anthracyclines in children younger than 2 years old with acute myeloid leukemia

  • {{article.zuoZheEn}}
Author information +
History +

Highlights

{{article.highlightEn}}

Abstract

{{article.abstractEn}}

Author summary

{{article.authorSummayEn}}

Keywords

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾
{{article.zuoZheEn_L}}. {{article.titleEn}}. Front. Med., 2019, 13(3): 378‒387 https://doi.org/10.1007/s11684-018-0658-4

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

RIGHTS & PERMISSIONS

{{article.copyright.year}} {{article.copyright.holder}}
AI Summary AI Mindmap
PDF(679 KB)

Accesses

Citations

Detail
Sections
Recommended

/

〈 〉